Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Treasury Shares (2022 - 2023)

Zentalis Pharmaceuticals (ZNTL) has 3 years of Treasury Shares data on record, last reported at $2.1 million in Q4 2024.

  • For Q4 2024, Treasury Shares rose 70.17% year-over-year to $2.1 million; the TTM value through Dec 2024 reached $2.1 million, up 70.17%, while the annual FY2024 figure was $2.1 million, 70.17% up from the prior year.
  • Treasury Shares reached $2.1 million in Q4 2024 per ZNTL's latest filing, up from $1.2 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.1 million in Q4 2024 and bottomed at $125506.0 in Q4 2022.
  • Average Treasury Shares over 3 years is $1.1 million, with a median of $1.2 million recorded in 2023.
  • Peak YoY movement for Treasury Shares: skyrocketed 871.12% in 2023, then skyrocketed 70.17% in 2024.
  • A 3-year view of Treasury Shares shows it stood at $125506.0 in 2022, then surged by 871.12% to $1.2 million in 2023, then skyrocketed by 70.17% to $2.1 million in 2024.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $2.1 million in Q4 2024, $1.2 million in Q4 2023, and $125506.0 in Q4 2022.